MASLD: ‘Elephant in the Room’ of #CKM
🔹 🌍 crisis: 1/3 adults affected, 65% in #T2D
🔸 Liver fibrosis=predictor of ☠️ & #CVD, #CKD,&HCC
🔹 No approved Rx – 🎯 lifestyle, ⤵️weight & multi-specialty care
🔸 Future hope: GLP-1s, PPAR, THR-β agonists
👉 Access the full paper via link
🔗 ggdocs.co/dz0kai 
